Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $54.77 | Prev. Close $54.15 | Circuit Range N/A |
Day Range $54.05 - $55.27 | Year Range $28.19 - $63.50 | Volume 15,402 |
Average Traded $54.46 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $54.46 | $54.68 | +1.09% |
19-May-26 | $53.41 | $54.09 | +0.63% |
18-May-26 | $54.70 | $53.75 | -1.09% |
15-May-26 | $55.39 | $54.34 | -2.97% |
14-May-26 | $56.05 | $56.01 | +0.24% |
13-May-26 | $54.69 | $55.87 | +1.60% |
12-May-26 | $55.91 | $54.99 | -1.47% |